Dendri Therapeutics

Dendri Therapeutics is a biotechnology company focused on the clinical development of therapeutic vaccines for cancer. Founded in 2003 by Dr. Anthony E. Maida, III, the company specializes in immunotherapy approaches, likely utilizing dendritic cell-based technologies to stimulate the immune system against various malignancies. While the company has maintained a low public profile, it is part of a broader network of oncology-focused ventures led by Dr. Maida, who has held leadership roles at Spectrum Pharmaceuticals and Northwest Biotherapeutics. Dendri Therapeutics aims to advance novel vaccine candidates through early-stage clinical trials to address unmet needs in oncology.